Home A survey of bacterial, fungal and plant metabolites against Aedes aegypti (Diptera: Culicidae), the vector of yellow and dengue fevers and Zika virus
Article Open Access

A survey of bacterial, fungal and plant metabolites against Aedes aegypti (Diptera: Culicidae), the vector of yellow and dengue fevers and Zika virus

  • Marco Masi EMAIL logo , Alessio Cimmino , Nurhayat Tabanca , James J. Becnel , Jeffrey R. Bloomquist and Antonio Evidente
Published/Copyright: June 14, 2017

Abstract

Aedes aegypti L. is the major vector of the arboviruses responsible for dengue fever, one of the most devastating human diseases. Some bacterial, fungal and plant metabolites belonging to different chemical subgroups, including Amaryllidaceae alkaloids, anthracenes, azoxymethoxytetrahydropyrans, cytochalasans, 2,5-diketopiperazines, isochromanones, naphthoquinones, organic small acids and their methyl esters, sterols and terpenes including sesquiterpenes and diterpenes, were tested for their larvicidal and adulticidal activity against Ae. aegypti. Out of 23 compounds tested, gliotoxin exhibited mosquitocidal activity in both bioassays with an LC50 value of 0.0257 ± 0.001 µg/µL against 1st instar Ae. aegypti and LD50 value of 2.79 ± 0.1197 µg/mosquito against adult female Ae. aegypti. 2-Methoxy-1,4-naphthoquinone and cytochalasin A showed LC50 values of 0.0851 ± 0.0012 µg/µL and 0.0854 ± 0.0019 µg/µL, respectively, against Ae. aegypti larvae. In adult bioassays, fusaric acid (LD50= 0.8349 ± 0.0118 µg/mosquito), 3-nitropropionic acid (LD50 = 1.6641 ± 0.0494 µg/mosquito) and α-costic acid (LD50 = 2.547 ± 0.0835 µg/mosquito) exhibited adulticidal activity. Results from the current study confirm that compounds belonging to cytochalsin, diketopiperazine, naphthoquinone and low molecular weight organic acid groups are active and may stimulate further SAR investigations.

1 Introduction

Dengue fever causes significant human illness and mortality worldwide, especially in the tropics and subtropical regions [1]. Dengue fever, also known as a break-bone fever, is an infectious disease caused by the tropical dengue virus [2, 3]. The disease is transmitted by mosquitoes of the genus Aedes, especially the species Aedes aegypti L. (Diptera: Culicidae) [4]. Typical symptoms of the disease are fever, headache, muscle and joint pain, in addition to a characteristic rash similar to measles [5]. The incidence of dengue has grown rapidly, by a factor of thirty since the 1960’s. Between 1960 and 2010, human population growth and migration increased and 50-100 million people were infected with dengue fever each year. Prevention of the disease is based on controlling the mosquito population vector and protection from contact with the residents of endemic areas [1]. One dengue vaccine (CYD-TDV, or Dengvaxia®) has been registered and several of other dengue vaccine candidates are in clinical development. The two most advanced candidates are currently under evaluation in Phase 3 trials [6].

Ae. aegypti is also one of the vectors of Zika virus [7]. The clinical presentation of Zika fever is nonspecific and can be misdiagnosed as the first infections were associated with flu-like symptoms [8]. In addition, severe neurological complications were reported in the French Polynesian outbreak in 2013 and 2014, and later a dramatic increase in congenital malformations (microcephaly) were reported from Zika emergence in Brazil [7]. Although there is no vaccine to control the Zika virus, several attempts are in the development phase. Preventative measures are therefore the same as cited above for Ae. aegypti-borne diseases [9].

The main method of control of Ae. aegypti is the elimination of its habitat [10, 11], which can be achieved in disease-endemic areas by emptying any standing containers of water. The most widely used larvicide worldwide for mosquitoes is Bacillus thuringiensis israelensis (Bti). Application of Bti has been used to reduce the number of mosquitoes, including Ae. aegypti [10, 11]. Another method is the use of animal species that prey on the vector, such as Poecilia reticulata or copepods that feed on their larvae or the immature stages of Toxorhynchites spp. that can consume mosquito larvae in tree crevices. Wolbachia-infected Ae. aegypti for dengue fever control can be another biocontrol approach [11]. Repellents applied to skin or clothing are also recommended as a means of personal protection against biting arthropods [12]. Insecticides, such as pyrethroids and organophosphates [13] can also be used. Synthetic and natural compounds, including pyrethroids, are approved by the EPA (Environmental Protection Agency) for use as repellents, but only when applied to clothing [14]. However, use of pyrethroids for control of a wide range of arthropods has given rise to environmental and health concerns [15-17]. These problems were increased by the development of resistance against pyrethroids and other insecticides, and this resistance has prompted the design of alternative control strategies [16-18]. Therefore, great effort has been expended on the development of pest controls using naturally occurring compounds such as secondary plant and fungal metabolites. Many naturally occurring repellents and insecticides have the potential for development into useful products with lowered risk to mammals and the environment [19-21]. As a consequence, the search for new anti-dengue agents from medicinal plants has become more urgent than in the past and the results of these studies were recently reviewed [12, 22, 23].

Microbial phytotoxins are a source of natural products and have been extensively investigated in agrochemical discovery by Evidente and coauthors [24-31]. For example, some fungal phytotoxins such as cyclopaldic acid, seiridin, sphaeropsidin A and papyracillic acid were evaluated for their biting deterrent and larvicidal activities against 1st instar Ae. aegypti[32]. Furthermore, papyracillic acid isolated from a solid culture of Ascochyta agropyrina var. nana showed potential herbicide activity against quack grass Elytrigia repens[24]. These promising results stimulated the preparation of semisynthetic derivatives of papyracillic acid and investigation of the structure-activity relationships of active deterrent compounds in a subsequent study [33].

In our continuing effort to find new natural mosquitocidal agents, several fungal and plant metabolites belonging to diverse structural classes, including; alkaloids, anthracenes, azoxymethoxytetrahydropyrans, cytochalasans, 2,5-diketopiperazines, isochromanones, naphthoquinones, small organic acids and their methyl esters, sterols, and terpenes were evaluated against Ae. aegypti.

2 Experimental

2.1 General

All the metabolites used to test for insecticidal activity against Ae. aegypti are shown in Figure 1 and reported in Table 1, which also contains the compound source and the corresponding literature [28, 29, 34-46]. Purity of each compound was ascertained by TLC, NMR and ESI-MS using established methods. 1H NMR spectra were recorded at 400 MHz, on Bruker spectrometer (Bruker BioSpin GmbH., Karlshrue, Germany), using the same solvent as used for the internal standard. ESI MS spectra were recorded on Agilent Technologies 6120 quadrupole LC/MS instrument (Agilent instruments, Milan, Italy); analytical and preparative thin layer chromatography (TLC) were performed on silica gel (Kieselgel 60, F254, 0.25 and 0.5 mm respectively) plates (Merck, Darmstadt, Germany); the spots were visualized by exposure to UV light or by spraying with 10% H2SO4 in CH3OH and then 5% phosphomolybdic acid in EtOH, followed by heating at 110°C for 10 min.

Figure 1 Structures of bacterial, fungal and plant metabolites assayed against Ae. aegypti
Figure 1

Structures of bacterial, fungal and plant metabolites assayed against Ae. aegypti

Table 1

Bacterial, fungal and plant metabolites assayed against Ae. aegypti

#NameChemical FamilySourceRef.
1BuphanamineAlkaloidsThe compound was supplied by Dr. H. M. Fales, National Institutes of Health, Department of Health, Education, and Welfare, Bethesda, MD.41
2ChenopodolinTerpenesFungus: Phoma chenopodiicola29
3ChloromonilicinXanthonesFungus: Alternaria sonchi39
4α-Costic acidTerpenesPlant: Inula viscosa42
5CycasinAzoxymethoxytetrahydropyransPlant: Cycas revoluta25
6Cytochalasin ACytochalasansFungus: Pyrenophora semeniperda35
7Cytochalasin BCytochalasansFungus: Pyrenophora semeniperda36,37
8Fusaric acidOrganic acidsFungus: Fusarium oxysporum f. sp. pisi43
9Gliotoxin2,5-DiketopiperazinesFungus: Neosartorya pseudofischeri38
10HaemanthamineAlkaloidsPlant: Narcissus pseudonarcissus “King Alfred”41
11HaemanthidineAlkaloidsPlant: Lycoris aurea41
126-HydroxymelleinIsochromanonesFungus: Phoma chenopodiicola29
13Inuloxin ATerpenesPlant: Inula viscosa42
14Inuloxin CTerpenesPlant: Inula viscosa42
152-Methoxy-1,4-naphthoquinoneNaphthoquinonesPlant: Impatiens glandulifera40
163-Nitropropionic acidOrganic acidsFungus: Diaporthe gulyae44
17PapulineOrganic acids and methyl estersBacterium: Pseudomonas syringae pv. papulans34
18Pyripyropene AAnthracenesFungus: Neosartorya pseudofischeri38
19Pyripyropene EAnthracenesFungus: Neosartorya pseudofischeri38
201,8a-Dihydroxy-3,8-dimethyl-5-(prop-1-en-2-yl)-1,2,4a,5,6,7,8,8a-octahydronaphthalen-2-ylacetateTerpenesFungus: Neosartorya pseudofischeri38
21Sphaeropsidin CTerpenesFungus: Diplodia quercivora45
22α-SpinasterolSterolsPlant: Impatiens glandulifera40
23UngeremineAlkaloidsPlant: Pancratium maritimum41

2.2 Mosquitoes

Aedes aegypti larvae and adults used in this study were from laboratory colonies maintained at the USDA-ARS, CMAVE, Gainesville, Florida, USA. The “Orlando” strain was collected near Orlando, Florida, USA in 1952 and has been in continuous laboratory colony for 65 years. Rearing procedures are standardized and have been described previously [47]. Technical-grade permethrin (Chem Service, West Chester, PA, USA), a combination of 46.1% cis and 53.2% trans isomers, was used as the positive control in all assays.

2.2.1 Larvicidal activity

For larval bioassays (Fig. 2), all compounds were initially diluted in DMSO to make 100 µg/µL. Mortality was determined in the larval assays at four different concentrations (1.0, 0.5, 0.25, and 0.1 µg/µL) in a final volume of 200 µL of larval rearing media that contained five 1st instar Ae. aegypti larvae. Larval assays were performed using a 96-well plate and the larvae were provided with 10 µL of the supernatant from a 2% solution of 1:1 alfalfa powder: pig chow. For each assay, a positive control of permethrin and a negative control of DMSO was included. Mortality data were recorded 24 hours post-exposure. Assays were repeated at least three times on different days.

Figure 2 Larval bioassay against 1st instar Ae. aegypti, a) preparing samples to assay; b) each well contains 5 larvae; c) After treatments, samples were kept in 96-well plates were kept at room temperature
Figure 2

Larval bioassay against 1st instar Ae. aegypti, a) preparing samples to assay; b) each well contains 5 larvae; c) After treatments, samples were kept in 96-well plates were kept at room temperature

2.3.2 Adulticidal activity

To determine the toxicity of each sample against adult female Ae. aegypti, samples were initially diluted to a 10% DMSO solution that was subsequently serially diluted 1:10 in acetone. Mosquitoes were anesthetized on ice and groups of 10 females sorted into individual plastic cups. Application of 0.5 µL of the sample solution was applied to dorsal thorax using a Hamilton 700 series syringe and a PB600 repeating dispenser (Thermo Fisher Scientific, Hampton, NH, USA) at a discriminating dose of 5 µg/mosquito. After treatment, mosquitoes were kept in plastic cups and supplied with 10% sucrose solution (Fig. 3). Mortality data were recorded 24 hours post-exposure. Assays were repeated at least three times on different days. For each assay, a positive control of permethrin and a negative control of acetone was included. Statistical analysis for both assays was performed in SigmaPlot.v13 using the best fit sigmoidal plot with the minimum and maximum constrained to 0% and 100%, respectively.

Figure 3 Adult bioassay against female Ae. aegypti, a) selecting female mosquitoes; b) compounds were topically applied to individual mosquitoes; c) After treatments, mosquitoes were kept in plastic cups with 10% sucrose solution for 24 h before mortality was recorded
Figure 3

Adult bioassay against female Ae. aegypti, a) selecting female mosquitoes; b) compounds were topically applied to individual mosquitoes; c) After treatments, mosquitoes were kept in plastic cups with 10% sucrose solution for 24 h before mortality was recorded

LC50 and LD50 values and 95% confidence intervals (95% CI) were determined for compounds that produced ~80% mortality at the discriminating dose in both larval and adult assays respectively. This was accomplished by using a descending dose series and replicated at least three times. Values were determined by plotting dose-mortality data to a 4-parameter logistic sigmoidal non-linear regression as implemented by SigmaPlot v13.

3 Results and Discussion

The metabolites isolated from bacteria, fungi, and plants belong to several different classes of natural compounds (Table 1) were investigated for the first time to evaluate them as new insecticidal agents against Ae. aegypti. In larval bioassays, mortality was determined at four final concentrations, 1.0, 0.5, 0.25 and 0.1 µg/µL. Out of the 23 compounds (Fig. 1), only three compounds, cytochalasin A (6), gliotoxin (9) and 2-methoxy-1,4-naphthoquinone (15), produced over 80% mortality (Table 2) and subsequently, dose-response bioassays were performed. Compound 9 showed the highest mortality with an LC50 of 0.0257 ± 0.001 µg/µL and followed by compounds 15 (LC50 = 0.0851 ± 0.0012 µg/µL) and 6 (LC50 = 0.0854 ± 0.0019 µg/µL) (Table 2).

Table 2

Larvicidal and adulticidal activity of bacterial, fungal and plants metabolites against Ae. aegpyti

#Compound Name[*]Log P[**]Larvicidal activity against 1st instar Ae. aegypti[***]Adulticidal activity against adult female Ae. aegypti
Percent mortality %LC5±SE µS/µL95%CIR2Percent mortality %
1 µS/µL0.5 µg/µL0.25 µg/µL0.1 µg/µL5 µg/mosquitoLD5±SE µg/mosq.95%CIR2
1Buphanamine2.642±000033.3 ±5.8
0.693
2Chenopodolin1.389±000020 ±10
0.649
3Chloromonilicin2.502±93.3±40±200026.7 ±5.8
0.99211.5
4α-Costic acid4.794±10046.7±6.7±11.5086.7 ± 5.82.547±(2.3421-2.7797)0.9024
0.31411.50.0835
5Cycasin-2.699±23.1±6.7±0026.7 ±11.5
0.52111.511.5
6Cytochalasin A1.849±10010010093.3±0.0854±(0.0809-0.890340 ±10
0.54311.50.00190.0897)
7Cytochalasin B3.203±26.7±00023.3 ±5.8
0.54723.1
8Fusaric acid2.165±10033.3±13.3±6.7±11.593.3 ±5.80.8349±(0.8091-0.8806)0.9545
0.022911.511.50.0118
9Gliotoxin3.051±1001001001000.0257±(0.0238-0.923083.3 ±5.82.79±(2.5165-3.0479)0.9509
0.9060.0010.0283)0.1197
10Haemanthamine1.828±4026.7±6.7±11.5046.7 ±5.77
0.71311.5
11Haemanthidine1.039±2000053.3 ±5.77
0.805
126-Hyd roxymelleir1 2.331±6.7±00020 ±10
0.50211.5
13Inuloxin A0.623±10073.3±26.7±13.3±40 ±10
0.43511.511.511.5
14Inuloxin C1.032±53.3±26.7±13.3±023.3 ±5.8
0.41211.511.511.5
152-Methoxy-l,4-1.895±1001001001000.0851±(0.0821-0.900040 ±10
naphthoquinone0.6570.00120.0 874)
163-Nitropropionic-0.308±10010033.3±40±2096.7 ±5.81.6641±(1.5445-1.7898)0.9377
acid0.24511.50.0494
17Papuline1.265±000053.3 ±5.8
0.257
18Pyripyropene A3.882±206.7±0060± 10
0.70611.5
19Pyripyropene E6.332±6.7±00056.7 ± 5.8
0.66811.5
20l,8a-Dihydroxy-2.521±000066.7 ±5.77
3,8-dimethyl-5-(prop-l-en-2-yl)-1,2,4a,5,6,7,8,8a-0.392
21Sphaeropsidin C4.044±13.3±6.7±0050 ±10
0.43011.511.5
22α-Spinasterol10.316±000026.7 ±11.5
0.294
23Ungeremine-1.82000023.3 ±5.8

In adult bioassays, compounds were tested at the pre-screening dose of 5 µg/mosquito and only four compounds, α-costic acid (4), fusaric acid (8), gliotoxin (9) and 3-nitropropionic acid (16), demonstrated mortality between 83-97% (Table 2). Based on this initial screening activity data, LD50 bioassays were conducted and compound 8 was the most effective compounds with an LD50 value of 0.8349 ± 0.0118 µg/mosquito and followed by compounds 16 (LD50 value = 1.6641 ± 0.0494 µg/mosquito), 4 (LD50 value = 2.547 ± 0.0835 µg/mosquito), 9 (LD50 value= 2.79 ± 0.1197 µg/mosquito) (Table 2).

Among the most active compounds, gliotoxin (9) possessed the best larvicidal activity, whereas fusaric acid (8) demonstrated the greatest adulticidal activity. Compounds chloromonilicin (3), a-costic acid (4), fusaric acid (8), inuloxin A (13) and 3-nitroprpionic acid (16) showed >90% mortality at the 1.0 µg/µL; however, the activity declined quickly as the compound was diluted. In adult bioassays, compounds (20), pyripyropene A (18), pyripyropene E (19), haemanthidine (11), sphaeropsidin C (21), haemanthamine (10) and cytochalasin A (6) exhibited moderate activity and weak activity was displayed by buphanamine (1), chloromonilicin (3), cytochalasin B (7), inuloxin C (14) and 6-hydroxymellein (12). There was no correlation between log P values and adult or larval toxicity (Table 2).

Although compounds showing lavicidal and adulticidal activity belong to different classes of natural compounds, such as diketpiperazines, cyochalasans, naphthoquinones and low molecular weight acids, it seems interesting to compare the high activity of cytochalasin A to the near inactivity of cytochalasin B. In this case, the data confirm the importance of the functional group at C-20, as well as the conformational freedom of the macrocycle for this group of natural compounds. Similar structural impacts were previously observed in tests of their phytotoxic, antimicrobial, cytotoxic, and zootoxic activities [27, 48-52]. Recently, Van Goietsenoven et al. [53] studied the structure activity relationships (SAR) of eight natural and three hemisynthetic derivatives of cytochalasins and they found that the presence of the hydroxy group at C-7, the functional group at C-20, and the conformational freedom of the macrocyclic ring appeared to also be important structural features for the inhibitory effect on cancer cells.

The compounds buphanamine (1), haemanthamine (10), and haemanthidine (11) belong to the crinine subgroup of the Amaryllidceae alkaloids [54], and they are defined by the ethane bridge that joins rings B and C, although they have an opposite stereochemistry. As compounds 10 and 11 showed similar adulticidal activity and a lesser larvicidal activity (Table 2), the presence of the hydroxy group on B-ring in 11 seems to not affect these activities. Thus, the lack of larvicidal activity of 1, with respect to that of 10 and 11, could be due to the different stereochemistry of the above cited ethane bridge, which probably affects negatively its interaction with the receptor and perhaps also the different functionalization of the C ring and the presence of the methoxy group at the aromatic A ring.

Inuloxins A (13) and C (14) are both sesquiterpenes, but belong to two different subgroups as germacranes and eudesmanolides, respectively. They are characterized by differences in the carbon skeleton generated from divergent biosynthesis of the common farnesyl-OPP precursor [55]. In our studies, their larvicidal and adulticidal activity was differentiated by inuloxin A (13) being 2-fold more toxic than inuloxin C (14) to Aedes larvae and adults (Table 2).

4 Conclusions

Current and future insect control mainly relies upon synthetic insecticides; in particular, control of vector-borne diseases would not be effective without these compounds. However, the development of resistance and adverse effect on the environment and human health have become apparent. Natural-based pesticides are often considered a low-risk substitute for conventional chemical insecticides. Though commercial adaptation of natural-based insecticides has been less than expected, continuing scientific studies and growing public awareness are inspiring the development of natural products as new lead insecticides. Pyrethrins are a good example of natural insecticides and their synthetic analogs, pyrethroids, are currently used in numerous formulations for the control of insect pests on animals and in the environment [56]. Microbially produced biopesticides such as abamectins, milbemectin, and spinosyns were developed as insecticides [57], with abamectins and spinosyns synthetically modified to possess higher efficacy for lepidopteran species [58]. Fungi-derived natural products have been an excellent source of pharmaceuticals as well, such as penicillins, cholesterol-lowering lovastatin, echinocandin B, and immunosuppressive cyclosporin A, proving the importance of investigating fungal sources for new medicines [59, 60]. Also the plants are a very good source of compounds with different biological activities and mode of actions. Recently, three new alkaloids, isolated from the South African plant Nerine sarniensis, showed insecticidal activity against Ae. Aegypti [61, 62].

Results from the current study have stimulated further structure-activity investigations with respect to the mosquitocidal activity of compounds belonging to diketopiperazine, cytochalasan, naphthoquinone and low molecular weight organic acid groups. Further studies are necessary to determine their potential activity against a wide range of insects and these five compounds [a-costic acid (4), cytochalasin A (6), gliotoxin (9), 2-methoxy-1,4-naphthoquinone (15) and 3-nitropropionic acid (16)] could be chemically optimized to improve their insecticidal activity. Finally, microbial metabolites are produced in relatively large quantities by fungi and may be a source of alternatives for insecticidal control of Ae. aegypti.

  1. Disclaimer: No potential conflict of interest was reported by the authors.

Acknowledgements

This study was partly funded by the Deployed War-Fighter Protection Research Program via grants from the U.S. Department of Defense through the Armed Forces Pest Management Board (to JJB and 58-0208-5-001 to JRB). We thank Miss Jessica Louton and Dr. Alden S. Estep (USDA-ARS, CMAVE, Gainesville, FL) for mosquito bioassays. Prof. A. Evidente is associated to Istituto di Chimica Biomolecolare, CNR, Pozzuoli, Italy.

References

[1] WHO, Dengue guidelines for diagnosis, treatment, prevention and control. WHO Press, World Health Organization, Geneva, 2009, pp 1-144.Search in Google Scholar

[2] Clarke T. Dengue virus: Break-bone fever, Nature, 2002, 416,672-674.10.1038/news020415-10Search in Google Scholar

[3] Reiter P. Yellow fever and dengue: A threat to Europe? Euro Surveill, 2010, 15, 19509.10.2807/ese.15.10.19509-enSearch in Google Scholar

[4] Swale D.R., Engers D.W., Bollinger S.R., Gross A., Inocente E.A., Days E., Kanga F., Johnson R.M., Yang L., Bloomquist J.R., Hopkins C.R., Piermarini P.M., Denton J.S. An insecticide resistance-breaking mosquitocide targeting inward rectifier potassium channels in vectors of Zika virus and malaria, Sci. Rep., 2016, 6, 36954.10.1038/srep36954Search in Google Scholar

[5] Whitehorn J., Farrar J. Dengue, Br. Med. Bull., 2010, 95, 161-173.10.1093/bmb/ldq019Search in Google Scholar

[6] WHO, Dengue vaccine: WHO position paper, 2016, 91, 349-364 (http://www.who.int/wer/2016/wer9130.pdf?ua=1, accessed on March 3, 2017).Search in Google Scholar

[7] Musso D., Gubler D.J. Zika virus: following the path of dengue and chikungunya? Lancet, 2015, 386, 243-244.10.1016/S0140-6736(15)61273-9Search in Google Scholar

[8] Nicolini A.M., McCracken K.E., Yoon J.Y. Future developments in biosensors for field-ready Zika virus diagnostics, J. Biol. Eng., 2017, 11, 7, doi: 10.1186/s13036-016-0046-z.10.1186/s13036-016-0046-zSearch in Google Scholar

[9] Musso D., Gubler D.J. Zika virus, Clinical Microbiol. Rev., 2016, 29, 487-524.10.1128/CMR.00072-15Search in Google Scholar

[10] Lacey L.A. Bacillus thuringiensis serovariety israelensis and Bacillus sphaericus for mosquito control, J. Am. Mosq. Control Assoc., 2007, 23 (2 Suppl), 133-163.10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2Search in Google Scholar

[11] Benelli G., Jeffries C.L., Waler T. Biological control of mosquito vectors: Past, present, and future, Insects, 2016, 7, 52.10.3390/insects7040052Search in Google Scholar

[12] Tabanca N., Bernier U.R., Agramonte N.M., Tsikolia M., Bloomquist J.R. Discovery of repellents from natural products, Curr. Org. Chem., 2016, 20, 2690-2702.10.2174/1385272820666160421151503Search in Google Scholar

[13] Hoel D., Pridgeon J.W., Bernier U.R., Chauhan K., Meepagala K., Cantrell C.L. Departments of defense and agriculture team up to develop new insecticides for mosquito control, Wingbeats, 2010, 21, 19-34.Search in Google Scholar

[14] Schreck C.E., Mount G.A., Carlson D.A. Wear and wash persistence of permethrin used as a clothing treatment for personal protection against the lone star tick (Acari: Ixodidae), J. Med. Entomol., 1982, 19, 143-146.10.1093/jmedent/19.2.143Search in Google Scholar PubMed

[15] Farias D.F., Cavalheiro M.G., Viana S.M., De Lima G.P., Da Rocha-Bezerra L.C., Ricardo N.M., Carvalho A.F. Insecticidal action of sodium anacardate from Brazilian cashew nut shell liquid against Aedes aegypti, J. Am. Mosquito Contr., 2009, 25, 386-389.10.2987/08-5851.1Search in Google Scholar PubMed

[16] Duke S.O., Cantrell C.L., Meepagala K.M., Wedge D.E., Tabanca N., Schrader K.K. Natural toxins for use in pest management, Toxins, 2010, 2, 1943-1962.10.3390/toxins2081943Search in Google Scholar PubMed PubMed Central

[17] Duke S.O., Baerson S.R., Cantrell C.L., Wedge D.E., Meepagala K.M., Pan Z., Rimando AM., Schrader K.K., Tabanca N., Owens D.K., Dayan, F.E. Phytochemicals for pest management: Current advances and future opportunities, Rec. Adv. Phytochem., 2014, 43, 71-94.10.1007/978-3-319-00581-2_5Search in Google Scholar

[18] Gross A.D., Tabanca N., Islam R., Ali A., Khan I.A., Kaplancikli Z.A., Altintop M.D., Ozdemir A., Bloomquist J.R. Toxicity and synergistic activities of chalcones against Aedes aegypti (Diptera: Culicidae) and Drosophila melanogaster (Diptera: Drosophilidae), J. Med. Entomol., 2016 (in press), doi: 10.1093/jme/tjw18310.1093/jme/tjw183Search in Google Scholar PubMed

[19] Dayan F.E., Cantrell C.L., Duke S.O. Natural products in crop protection, Bioorgan. Med. Chem., 2009, 14, 4022-4034.10.1016/j.bmc.2009.01.046Search in Google Scholar PubMed

[20] Evidente A. New fungal metabolites, as antifungal, herbicides and insecticides for biocontrol of agrarian pests, In: Gupta V.J. (Ed.), Comprehensive bioactive natural products, Studium Press LLC: Houston, 2010, p 333.Search in Google Scholar

[21] Cantrell C.L., Dayan F.E., Duke S.O. Natural products as sources for new pesticides, J. Nat. Prod., 2012, 75, 1231-1242.10.1021/np300024uSearch in Google Scholar PubMed

[22] Abd Kadir S.L., Yaakob H., Mohamed Zulkifli R. Potential anti-dengue medicinal plants: A review, J. Nat. Med., 2013, 67, 677-689.10.1007/s11418-013-0767-ySearch in Google Scholar PubMed PubMed Central

[23] Kishore N., Mishra B.B., Tiwari V.K., Tripathi V., Lall N. Natural products as leads to potential mosquitocides, Phytochem. Rev., 2014, 13, 587-627.10.1007/s11101-013-9316-2Search in Google Scholar

[24] Evidente A., Berestetskiy A., Cimmino A., Tuzi A., Superchi S., Melck D., Andolfi A. Papyracillic acid, a phytotoxic 1,6- dioxaspiro [4,4] nonene produced by Ascochyta agropyrina var. nana, a potential mycoherbicide for Elytrigia repens biocontrol, J. Agric. Food Chem., 2009, 57, 11168-11173.10.1021/jf903499ySearch in Google Scholar PubMed

[25] Cimmino A., Masi M., Evidente M., Superchi S., Evidente A. Fungal phytotoxins with potential herbicidal activity: chemical and biological characterization, Nat. Prod. Rep. 2015, 32, 1629-1653.10.1039/C5NP00081ESearch in Google Scholar

[26] Balde E. S., Andolfi A., Bruyère C., Cimmino A., Lamoral-Theys D., Vurro, M., Van Damme, M., Altomare C., Mathieu V., Kiss R., Evidente, A. Investigations of fungal secondary metabolites with potential anticancer activity, J. Nat. Prod., 2010, 73, 969-971.10.1021/np900731pSearch in Google Scholar

[27] Evidente A., Cimmino A., Andolfi A., Berestetskiy A., Motta A. Phomachalasins A–D, 26-oxa [16] and [15] cytochalasans produced by Phoma exigua var. exigua, a potential mycoherbicide for Cirsium arvense biocontrol, Tetrahedron, 2011, 67, 1557-1563.10.1016/j.tet.2010.12.058Search in Google Scholar

[28] Schrader KK., Andolfi A., Cantrell C.L., Cimmino A, Duke S.O., Osbrink W., Wedge D.E., Evidente A. A survey of phytotoxic microbial and plant metabolites as potential natural products for pest management. Chem. Biodiv., 2010, 7, 2261-2280.10.1002/cbdv.201000041Search in Google Scholar

[29] Cimmino A., Andolfi A., Zonno M.C., Avolio F., Santini A., Tuzi A., Berestetskyi A., Vurro M., Evidente A. Chenopodolin: a phytotoxic unrearranged ent-pimaradiene diterpene produced by Phoma chenopodicola, a fungal pathogen for Chenopodium album biocontrol, J. Nat. Prod., 2013, 76, 1291-1297.10.1021/np400218zSearch in Google Scholar

[30] Cimmino A., Andolfi A., Zonno MC., Avolio F., Berestetskiy A., Vurro M., Evidente A. Chenopodolans A–C: Phytotoxic furopyrans produced by Phoma chenopodiicola, a fungal pathogen of Chenopodium album, Phytochemistry, 2013, 96, 208-213.10.1016/j.phytochem.2013.10.007Search in Google Scholar

[31] Masi M., Cimmino A., Boari A., Tuzi A., Zonno M.C., Baroncelli R., Vurro M., Evidente A. Colletochlorins E and F, new phytotoxic tetrasubstituted pyran-2-one and dihydrobenzofuran, isolated from Colletotrichum higginsianum with potential herbicidal activity, J. Agric. Food Chem., 2017, 65, 1124-1130.10.1021/acs.jafc.6b05193Search in Google Scholar

[32] Cimmino A., Andolfi A., Avolio F., Ali A., Tabanca N., Khan I.A., Evidente A. Cyclopaldic acid, seiridin, and sphaeropsidin A as fungal phytotoxins, and larvicidal and biting deterrents against Aedes aegypti (Diptera: Culicidae): Structure-activity relationships. Chem. Biodivers, 2013, 10, 1239-1251.10.1002/cbdv.201200358Search in Google Scholar

[33] Cimmino A., Evidente M., Masi M., Ali A., Tabanca N., Khan, I.A., Evidente A. Papyracillic acid and its derivatives as biting deterrents against Aedes aegypti (Diptera: Culicidae): structure–activity relationships, Med. Chem. Res., 2015, 24, 3981-3989.10.1007/s00044-015-1439-0Search in Google Scholar

[34] Evidente A., lacobellis N.S., Scopa A., Surico G. Isolation of β-phenyllactic acid related compounds from Pseudomonas syringae, Phytochemistry, 1990, 29, 1491-1497.10.1016/0031-9422(90)80107-RSearch in Google Scholar

[35] Masi M., Meyer S., Cimmino A., Clement S., Black B., Evidente, A. Pyrenophoric acids B and C, two new phytotoxic sesquiterpenoids produced by Pyrenophora semeniperda. J. Agric. Food Chem. 2014,, 62, 10304-10311.10.1021/jf5035515Search in Google Scholar PubMed

[36] Masi M., Meyer S., Cimmino A., Andolfi A., Evidente A. Pyrenophoric acid, a phytotoxic sesquiterpenoid penta-2, 4-dienoic acid produced by a potential mycoherbicide, Pyrenophora semeniperda. J. Nat. Prod., 2014, 77, 925-930.10.1021/np4009915Search in Google Scholar PubMed

[37] Masi M., Evidente A., Meyer S., Nicholson J., Muñoz A. Effect of strain and cultural conditions on the production of cytochalasin B by the potential mycoherbicide Pyrenophora semeniperda (Pleosporaceae, Pleosporales). Biocontrol Sci.Technol., 2014, 24, 53-64.10.1080/09583157.2013.844769Search in Google Scholar

[38] Masi M., Andolfi A., Mathieu V., Boari A., Cimmino A., Banuls L.M.Y., Vurro M., Kornienko A., Kiss R., Evidente A. Fischerindoline, a pyrroloindole sesquiterpenoid isolated from Neosartorya pseudofischeri, with in vitro growth inhibitory activity in human cancer cell lines, Tetrahedron, 2013, 69, 7466-7470.10.1016/j.tet.2013.06.031Search in Google Scholar

[39] Cimmino A., Pescitelli G., Berestetskiy A., Dalinova A., Krivorotov D., Tuzi A., Evidente A. Biological evaluation and determination of the absolute configuration of chloromonilicin, a strong antimicrobial metabolite isolated from Alternaria sonchi, J. Antibiot., 2016, 69, 9-14.10.1038/ja.2015.74Search in Google Scholar PubMed

[40] Cimmino A., Mathieu V., Evidente M., Ferderin M., Banuls, L. M.Y., Masi, M., De Carvalho A., Kiss R., Evidente A. Glanduliferins A and B, two new glucosylated steroids from Impatiens glandulifera, with in vitro growth inhibitory activity in human cancer cells. Fitoterapia, 2016, 109, 138-145.10.1016/j.fitote.2015.12.016Search in Google Scholar PubMed

[41] Van Goietsenoven G., Andolfi A., Lallemand B., Cimmino A., Lamoral-Theys D., Gras T., Abou-Donia A., Dubois J., Lefranc F., Mathieu V., Kornienko A., Kiss R., Evidente A. Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells, J. Nat. Prod., 2010, 73, 1223-1227.10.1021/np9008255Search in Google Scholar PubMed

[42] Andolfi A., Zermane N., Cimmino A., Avolio F., Boari A., Vurro M., Evidente A. Inuloxins A–D, phytotoxic bi-and tri-cyclic sesquiterpene lactones produced by Inula viscosa: potential for broomrapes and field dodder management, Phytochemistry, 2013, 86, 112-120.10.1016/j.phytochem.2012.10.003Search in Google Scholar PubMed

[43] Bani M., Rispail N, Evidente A, Rubiales D., Cimmino A. Identification of the main toxins isolated from Fusarium oxysporum f. sp. pisi race 2 and their relation with isolates’ pathogenicity, J. Agric. Food Chem., 2014, 62, 2574-2580.10.1021/jf405530gSearch in Google Scholar PubMed

[44] Andolfi A., Boari A., Evidente M., Cimmino A., Vurro M., Ash G., Evidente A. Gulypyrones A and B and phomentrioloxins B and C produced by Diaporthe gulyae, a potential mycoherbicide for saffron thistle (Carthamus lanatus). J. Nat. Prod., 2015, 78, 623-629.10.1021/np500570hSearch in Google Scholar PubMed

[45] Andolfi A., Maddau L., Basso S., Linaldeddu B., Cimmino A., Scanu B., Deidda A., Tuzi A., Evidente A. Diplopimarane, a 20-nor-ent-pimarane produced by the oak pathogen Diplodia quercivora, J. Nat. Prod., 2014, 77, 2352-2360.10.1021/np500258rSearch in Google Scholar

[46] Lallemand B., Masi M., Maddau L., De Lorenzi M., Dam R., Cimmino A., Moreno Y Banuls L., Andolfi A. Kiss, R., Mathieu, V., Evidente, A. Evaluation of in vitro anticancer activity of sphaeropsidins A–C, fungal rearranged pimarane diterpenes, and semisynthetic derivatives. Phytochem. Lett., 2012, 5, 770-775.10.1016/j.phytol.2012.08.011Search in Google Scholar

[47] Pridgeon J.W., Pereira R.M., Becnel J.J., Allan S.A., Clark G.G., Linthicum K.J. Susceptibility of Aedes aegypti, Culex quinquefasciatus Say, and Anopheles quadrimaculatus Say to 19 pesticides with different modes of action, J. Med. Entomol., 2008, 45, 82-87.10.1603/0022-2585(2008)45[82:SOAACQ]2.0.CO;2Search in Google Scholar

[48] Bottalico A., Capasso R., Evidente A., Randazzo G., Vurro M. Cytochalasins: structure-activity relationships, Phytochemistry, 1990, 29, 93-96.10.1016/0031-9422(90)89018-5Search in Google Scholar

[49] Capasso R., Evidente A., Vurro M. Cytochalasins from Phoma exigua var. heteromorpha, Phytochemistry, 1991, 30, 3945-3950.10.1016/0031-9422(91)83442-NSearch in Google Scholar

[50] Vurro M., Bottalico A., Capasso R., Evidente A. Cytochalasins from phytopathogenic Ascochyta and Phoma species, In: Upadhyay R.K., Mukerji K.G. (Eds.), Toxins in Plant Disease Development and Evolving Biotechnology. Oxford & IBH Publishing Co. PVT. LTD, New Delhi, 1997, pp. 127–147.Search in Google Scholar

[51] Berestetskiy A., Dmitriev A., Mitina G., Lisker I., Andolfi A., Evidente A. Nonenolides and cytochalasins with phytotoxic activity against Cirsium arvenseSonchus arvensis: A structure–activity relationships study, Phytochemistry, 2008, 69, 953-960.10.1016/j.phytochem.2007.11.003Search in Google Scholar

[52] Cimmino A., Andolfi A., Berestetskiy A., Evidente A. Production of phytotoxins by Phoma exigua var. exigua, a potential mycoherbicide against perennial thistles, J. Agric. Food Chem., 2008, 56, 6304-6309.10.1021/jf8004178Search in Google Scholar

[53] Van Goietsenoven, G., Mathieu V., Andolfi A., Cimmino A., Lefranc F., Kiss R., Evidente A. In vitro growth inhibitory effects of cytochalasins and derivatives in cancer cells. Planta Med., 2011, 77, 711-717.10.1055/s-0030-1250523Search in Google Scholar

[54] Kornienko A., Evidente A. Chemistry, biology, and medicinal potential of narciclasine and its congeners, Chem. Rev., 2008, 108, 1982-2014.10.1021/cr078198uSearch in Google Scholar

[55] Dewick M.P. Medicinal Natural Products – A Biosynthetic approach. John Wiley & Son, Ltd, 2009.10.1002/9780470742761Search in Google Scholar

[56] Anadon A., Martínez-Larranãga M.R., Martínez M.A. Use and abuse of pyrethrins and synthetic pyrethroids in veterinary medicine, Vet. J., 2009, 182, 7-20.10.1016/j.tvjl.2008.04.008Search in Google Scholar PubMed

[57] Seiber J.N., Coats J., Duke S.O., Gross A.D. Biopesticides: state of the art and future opportunities, J. Agric. Food Chem., 2014, 62, 11613-11619.10.1021/jf504252nSearch in Google Scholar PubMed

[58] Gerwick B.C., Sparks T.C. Natural products for pest control: an analysis of their role, value and future, Pest Manag. Sci., 2014, 70, 1169-1185.10.1002/ps.3744Search in Google Scholar PubMed

[59] Evidente A., Kornienko A., Cimmino A., Andolfi A., Lefranc F., Mathieu V., Kiss R. Fungal metabolites with anticancer activity, Nat. Prod. Rep., 2014, 31, 617-627.10.1039/C3NP70078JSearch in Google Scholar PubMed

[60] Kornienko A., Evidente A., Vurro M., Mathieu V., Cimmino A., Evidente M., van Otterlo W., Dasari, R., Lefranc F., Kiss, R. Toward a cancer drug of fungal origin. Med. Res. Rev., 2015, 35, 937-967.10.1002/med.21348Search in Google Scholar PubMed PubMed Central

[61] Masi M., van der Westhuyzen A.E., Tabanca N., Evidente M., Cimmino A., Green I.R., Bernier U.R., Becnel J.J., Bloomquist J.R., van Otterlo W.A.L., Evidente A. Sarniensine, a mesembrine-type alkaloid isolated from Nerine sarniensis, an indigenous South African Amaryllidaceae, with larvicidal and adulticidal activities against Aedes aegypti. Fitoterapia, 2017, 116, 34-38.10.1016/j.fitote.2016.11.007Search in Google Scholar PubMed

[62] Masi M., Cala A., Tabanca N., Cimmino A., Green I.R., Bloomquist J.R., van Otterlo W.A.L., Macias F.A., Evidente A. Alkaloids with activity against the Zika Virus vector Aedes aegypti (L.)–crinsarnine and sarniensinol, two new crinine and mesembrine type alkaloids isolated from the South African plant Nerine sarniensis. Molecules, 2016, 21, 1432.10.3390/molecules21111432Search in Google Scholar PubMed PubMed Central

Received: 2017-3-9
Accepted: 2017-5-8
Published Online: 2017-6-14

© 2017 Marco Masi et al.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Articles in the same Issue

  1. Regular Articles
  2. Rare Coumarins Induce Apoptosis, G1 Cell Block and Reduce RNA Content in HL60 Cells
  3. Regular Articles
  4. Evaluation of the photocatalytic ability of a sol-gel-derived MgO-ZrO2 oxide material
  5. Regular Articles
  6. Extraction Methods for the Isolation of Isoflavonoids from Plant Material
  7. Regular Articles
  8. Micro and nanocomposites of polybutadienebased polyurethane liners with mineral fillers and nanoclay: thermal and mechanical properties
  9. Regular Articles
  10. Effect of pH on Structural, Magnetic and FMR Properties of Hydrothermally Prepared Nano Ni Ferrite
  11. Regular Articles
  12. Statistical approach to study of lithium magnesium metaborate glasses
  13. Regular Articles
  14. The effectiveness of biodrying waste treatment in full scale reactor
  15. Regular Articles
  16. Chemical comparison of the underground parts of Valeriana officinalis and Valeriana turkestanica from Poland and Kazakhstan
  17. Regular Articles
  18. Phytochemical Characterization and Biological Evaluation of the Aqueous and Supercritical Fluid Extracts from Salvia sclareoides Brot
  19. Regular Articles
  20. Recent Microextraction Techniques for Determination and Chemical Speciation of Selenium
  21. Regular Articles
  22. Compost leachate treatment using polyaluminium chloride and nanofiltration
  23. Regular Articles
  24. Facile and Effective Synthesis of Praseodymium Tungstate Nanoparticles through an Optimized Procedure and Investigation of Photocatalytic Activity
  25. Regular Articles
  26. Computational Study on Non-linear Optical and Absorption Properties of Benzothiazole based Dyes: Tunable Electron-Withdrawing Strength and Reverse Polarity
  27. Regular Articles
  28. Comparative sorption studies of chromate by nano-and-micro sized Fe2O3 particles
  29. Regular Articles
  30. Recycling Monoethylene Glycol (MEG) from the Recirculating Waste of an Ethylene Oxide Unit
  31. Regular Articles
  32. Antimicrobial activity and thiosulfinates profile of a formulation based on Allium cepa L. extract
  33. Regular Articles
  34. The effect of catalyst precursors and conditions of preparing Pt and Pd-Pt catalysts on their activity in the oxidation of hexane
  35. Regular Articles
  36. Platinum and vanadate Bioactive Complexes of Glycoside Naringin and Phenolates
  37. Regular Articles
  38. Antimicrobial sesquiterpenoids from Laurencia obtusa Lamouroux
  39. Regular Articles
  40. Comprehensive spectroscopic (FT-IR, FT-Raman, 1H and 13C NMR) identification and computational studies on 1-acetyl-1H-indole-2,3-dione
  41. Regular Articles
  42. A combined experimental and theoretical study on vibrational and electronic properties of (5-methoxy-1H-indol-1-yl)(5-methoxy-1H-indol-2-yl)methanone
  43. Regular Articles
  44. Erratum to: Analysis of oligonucleotides by liquid chromatography with alkylamide stationary phase
  45. Regular Articles
  46. Non-isothermal Crystallization, Thermal Stability, and Mechanical Performance of Poly(L-lactic acid)/Barium Phenylphosphonate Systems
  47. Regular Articles
  48. Vortex assisted-supramolecular solvent based microextraction coupled with spectrophotometric determination of triclosan in environmental water samples
  49. Regular Articles
  50. Investigation on Two Compounds of O,O’-dithiophosphate Derivatives as Corrosion Inhibitors for Q235 Steel in Hydrochloric Acid Solution
  51. Regular Articles
  52. Evaluation of temporary seasonal variation of heavy metals and their potential ecological risk in Nzhelele River, South Africa
  53. Regular Articles
  54. Synthesis, characterization, second and third order non-linear optical properties and luminescence properties of 1,10-phenanthroline-2,9-di(carboxaldehyde phenylhydrazone) and its transition metal complexes
  55. Regular Articles
  56. Spectrodensitometric simultaneous determination of esomeprazole and domperidone in human plasma
  57. Regular Articles
  58. Computer-aided drug design of capuramycin analogues as anti-tuberculosis antibiotics by 3D-QSAR and molecular docking
  59. Regular Articles
  60. Synthesis, characterization, thermal degradation and urease inhibitory studies of the new hydrazide based Schiff base ligand 2-(2-hydroxyphenyl)-3-{[(E)-(2-hydroxyphenyl)methylidene]amino}-2,3-dihydroquinazolin-4(1H)-one
  61. Regular Articles
  62. Quaternary salts derived from 3-substituted quinuclidine as potential antioxidative and antimicrobial agents
  63. Regular Articles
  64. Bio-concentration of Polycyclic Aromatic Hydrocarbons in the grey Mangrove (Avicennia marina) along eastern coast of the Red Sea
  65. Regular Articles
  66. Quantitative Investigation of Roasting-magnetic Separation for Hematite Oolitic-ores: Mechanisms and Industrial Application
  67. Regular Articles
  68. Photobleaching characteristics of α-(8-quinolinoxy) zinc phthalocyanine, a new type of amphipathic complex
  69. Regular Articles
  70. Methane dry reforming over Ni catalysts supported on Ce–Zr oxides prepared by a route involving supercritical fluids
  71. Regular Articles
  72. Thermodynamic Compatibility, Crystallizability, Thermal, Mechanical Properties and Oil Resistance Characteristics of Nanostructure Poly (ethylene-co-methyl acrylate)/Poly(acrylonitrile-co-butadiene) Blends
  73. Regular Articles
  74. The crystal structure of compositionally homogeneous mixed ceria-zirconia oxides by high resolution X-ray and neutron diffraction methods
  75. Topical Issue on Agriculture
  76. Properties of the filtrate from treatment of pig manure by filtration method
  77. Topical Issue on Agriculture
  78. Monitoring content of cadmium, calcium, copper, iron, lead, magnesium and manganese in tea leaves by electrothermal and flame atomizer atomic absorption spectrometry
  79. Topical Issue on Catalysis
  80. Application of screen-printed carbon electrode modified with lead in stripping analysis of Cd(II)
  81. Topical Issue on Research for Natural Bioactive Products
  82. Burdock (Arctium lappa) Leaf Extracts Increase the In Vitro Antimicrobial Efficacy of Common Antibiotics on Gram-positive and Gram-negative Bacteria
  83. Topical Issue on Research for Natural Bioactive Products
  84. A survey of bacterial, fungal and plant metabolites against Aedes aegypti (Diptera: Culicidae), the vector of yellow and dengue fevers and Zika virus
  85. Topical Issue on Research for Natural Bioactive Products
  86. ‘Capiture’ plants with interesting biological activities: a case to go
  87. Topical Issue on Research for Natural Bioactive Products
  88. Volatile terpenoids as potential drug leads in Alzheimer’s disease
  89. Topical Issue on Research for Natural Bioactive Products
  90. Essential Oils as Immunomodulators: Some Examples
  91. Topical Issue on Research for Natural Bioactive Products
  92. Phenolic profiling and therapeutic potential of local flora of Azad Kashmir; In vitro enzyme inhibition and antioxidant
  93. Topical Issue on Research for Natural Bioactive Products
  94. Chemical profile, antioxidant activity and cytotoxic effect of extract from leaves of Erythrochiton brasiliensis Nees & Mart. from different regions of Europe
Downloaded on 22.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/chem-2017-0019/html
Scroll to top button